Perceptions and Representations of Cancer Chemotherapy (chemotherapy)
July 27, 2016 updated by: University Hospital, Montpellier
Qualitative study on data from interviews such patients, relatives and doctors involved in the implementation of cancer care.
Framework type of method using grounded theory
Study Overview
Status
Completed
Conditions
Detailed Description
The word chemotherapy itself, because it belongs to the secular knowledge and therefore Doxa is a hard word, which stores what it is stable, common and therefore impersonal. It has the properties of a symbol, that is to say that joint several meanings, some of which are contradictory.
The objective of the research:
To determine the perceptions and representations of chemotherapy, its physical impacts, psychological and relational.
To qualitatively compare the performances of chemotherapy as it has an end as scheduled for adjuvant chemotherapy, or endless precise as in the palliative chemotherapy
Study Type
Observational
Enrollment (Actual)
75
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 100 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
- 30 major Patients with lung cancer requiring chemotherapy either as palliative or adjuvant as surgical treatment
- 30 significant others (relatives) major applicant lung cancer patients chemotherapy either palliation or as adjuvant to surgery
- 15 Doctors oncologists performing either chemotherapy as palliative or adjuvant as surgical treatment
Description
Inclusion Criteria:
- 30 major Patients with lung cancer requiring chemotherapy either as palliative or adjuvant as surgical treatment
- 30 significant others (relatives) major applicant lung cancer patients chemotherapy either palliation or as adjuvant to surgery
- 15 Doctors oncologists performing either chemotherapy as palliative or adjuvant as surgical treatment
Exclusion Criteria:
- NA
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Patients requiring lung cancer chemotherapy
30 major Patients with lung cancer requiring chemotherapy either as palliative or adjuvant as surgical treatment having a semi-structured interview conducted by a clinical psychologist
|
semi-structured interview conducted by a clinical psychologist
|
|
Family of lung cancer patients receiving chemotherapy
30 Family of lung cancer patients receiving chemotherapy having a semi-structured interview conducted by a clinical psychologist
|
semi-structured interview conducted by a clinical psychologist
|
|
doctors caring for lung cancer patients receiving chemotherapy
15 doctors caring for lung cancer patients receiving chemotherapy 15 have a semi-structured interview conducted by a psychiatrist specialized in psycho-oncology
|
semi-structured interview conducted by a psychiatrist specialized in psycho-oncology
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The semi-structured interview
Time Frame: 1 day (day of inclusion)
|
The interview will be analyzed in a framework type of method (grounded theory) in accordance with the guidelines coreq.
|
1 day (day of inclusion)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2015
Primary Completion (Actual)
December 1, 2015
Study Completion (Actual)
December 1, 2015
Study Registration Dates
First Submitted
June 30, 2016
First Submitted That Met QC Criteria
July 27, 2016
First Posted (Estimate)
August 1, 2016
Study Record Updates
Last Update Posted (Estimate)
August 1, 2016
Last Update Submitted That Met QC Criteria
July 27, 2016
Last Verified
March 1, 2015
More Information
Terms related to this study
Other Study ID Numbers
- RECHMPL16_0208
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.